Parkinson's disease or symptomatic parkinsonism. May be used as monotherapy in early Parkinson's disease to delay the need for levodopa (w/ or w/o decarboxylase inhibitor). Adjunct to levodopa (w/ or w/o decarboxylase inhibitor).
View Selegos overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food.
Special Precautions
Potentiation of levodopa effects: side effects might be emphasized particularly in very high doses. May cause involuntary movement &/or agitation when added to maximal doses of levodopa. Not to be used in pregnancy & lactation.